INMUNE BIO INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
INMUNE BIO INC. (INMB) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $210.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $210.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $259.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $100.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $122.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $210.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $259.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $100.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $122.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $54.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $46.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $58.00K 10-K · filed 2025-03-27 | |
| 2024-06-30 | $83.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $96.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $112.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $69.00K 10-Q · filed 2024-10-31 | $260.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |